Benzinga's Top #PreMarket Losers
February 04, 2015 at 08:16 AM EST
Myriad Genetics Inc. (NASDAQ: MYGN) shares declined 16.92% to $31.67 in pre-market trading after the company cut its full-year outlook ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.